These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31158304)

  • 21. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
    Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
    Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.
    Adamek A; Kasprzak A; Mikoś H; Przybyszewska W; Seraszek-Jaros A; Czajka A; Sterzyńska K; Mozer-Lisewska I
    Oncol Rep; 2013 Sep; 30(3):1337-45. PubMed ID: 23784592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.
    Chen W; Wang S; Tian T; Bai J; Hu Z; Xu Y; Dong J; Chen F; Wang X; Shen H
    Eur J Hum Genet; 2009 Dec; 17(12):1668-75. PubMed ID: 19491931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time spent walking or exercising and blood levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3): A large-scale cross-sectional study in the Japan Collaborative Cohort study.
    Wakai K; Suzuki K; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():23-7. PubMed ID: 20553077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.
    Neuhouser ML; Schenk J; Song YJ; Tangen CM; Goodman PJ; Pollak M; Penson DF; Thompson IM; Kristal AR
    Prostate; 2008 Sep; 68(13):1477-86. PubMed ID: 18618736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF1 and IGFBP3 in acute respiratory distress syndrome.
    Ahasic AM; Zhai R; Su L; Zhao Y; Aronis KN; Thompson BT; Mantzoros CS; Christiani DC
    Eur J Endocrinol; 2012 Jan; 166(1):121-9. PubMed ID: 22004906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-sectional and longitudinal relation of IGF1 and IGF-binding protein 3 with lipid metabolism.
    Eggert ML; Wallaschofski H; Grotevendt A; Nauck M; Völzke H; Samietz S; Friedrich N
    Eur J Endocrinol; 2014 Jul; 171(1):9-19. PubMed ID: 24743393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating IGF1 and IGFBP3 in relation to the development of β-cell autoimmunity in young children.
    Peet A; Hämäläinen AM; Kool P; Ilonen J; Knip M; Tillmann V;
    Eur J Endocrinol; 2015 Aug; 173(2):129-37. PubMed ID: 25947142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
    Drogan D; Schulze MB; Boeing H; Pischon T
    Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.
    Cao Y; Lindström S; Schumacher F; Stevens VL; Albanes D; Berndt S; Boeing H; Bueno-de-Mesquita HB; Canzian F; Chamosa S; Chanock SJ; Diver WR; Gapstur SM; Gaziano JM; Giovannucci EL; Haiman CA; Henderson B; Johansson M; Le Marchand L; Palli D; Rosner B; Siddiq A; Stampfer M; Stram DO; Tamimi R; Travis RC; Trichopoulos D; Willett WC; Yeager M; Kraft P; Hsing AW; Pollak M; Lin X; Ma J
    J Natl Cancer Inst; 2014 Jun; 106(6):dju085. PubMed ID: 24824313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma insulinlike growth factor 1 and binding-protein 3 and risk of myocardial infarction in women: a prospective study.
    Page JH; Ma J; Pollak M; Manson JE; Hankinson SE
    Clin Chem; 2008 Oct; 54(10):1682-8. PubMed ID: 18703768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
    Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
    Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study.
    Wakai K; Ito Y; Suzuki K; Tamakoshi A; Seki N; Ando M; Ozasa K; Watanabe Y; Kondo T; Nishino Y; Ohno Y;
    Jpn J Cancer Res; 2002 Dec; 93(12):1279-86. PubMed ID: 12495466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B; Liu DB; Zhang X; DU LL; Han CZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.
    Yu H; Spitz MR; Mistry J; Gu J; Hong WK; Wu X
    J Natl Cancer Inst; 1999 Jan; 91(2):151-6. PubMed ID: 9923856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
    Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
    Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of IGF1 and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men.
    Yeap BB; Chubb SA; McCaul KA; Flicker L; Ho KK; Golledge J; Hankey GJ; Norman PE
    Eur J Endocrinol; 2012 Feb; 166(2):191-7. PubMed ID: 22113073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.